Form 4: Eli Lilly CEO David Ricks Reports Stock Transactions

Eli Lilly CEO David Ricks executed stock transactions involving the acquisition of shares through restricted stock units and the disposition of shares to cover tax obligations.

Summary

• David Ricks, CEO of Eli Lilly, reported transactions involving the company's common stock on February 1, 2024.
• He acquired 29,611 shares through the vesting of restricted stock units.
• He disposed of 13,240 shares to satisfy tax obligations at a price of $645.61 per share.
• Following these transactions, Mr. Ricks directly owns 441,814 shares of Eli Lilly common stock.
• He also has indirect ownership of 63,758 shares through a 2022 GRAT, 67,700 shares through a SLAT, and 7,223 shares through a 401(k).

Sentiment

Score: 7

Explanation: The document reflects routine executive stock transactions, which are neither particularly positive nor negative. The sentiment is neutral to slightly positive due to the vesting of stock units.

Positives

• The acquisition of shares through restricted stock units indicates a continued alignment of the CEO's interests with the company's performance.
• The vesting of restricted stock units is a common form of executive compensation.

Negatives

• The sale of shares, while likely for tax purposes, could be perceived negatively by some investors if not understood in context.

Risks

• Executive stock transactions can sometimes be misinterpreted by the market, leading to short-term price volatility.
• Changes in executive ownership can sometimes raise questions about management's long-term commitment, although this is a routine transaction.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are routinely disclosed to the SEC. This filing is a standard part of regulatory compliance.

Comparison to Industry Standards

• Executive stock transactions are a common practice across the pharmaceutical industry, with companies like Pfizer (PFE), Merck (MRK), and AbbVie (ABBV) also reporting similar filings.
• The use of restricted stock units as part of executive compensation is a standard practice in the industry.
• The sale of shares to cover tax obligations is also a common occurrence among executives.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they are routine executive stock transactions.
• Shareholders may be interested in tracking executive ownership as an indicator of management's alignment with company performance.

Key Dates

Keywords

Eli Lilly, LLY, David Ricks, stock transaction, restricted stock units, insider trading, SEC Form 4, executive compensation